Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI.DL)

CAPS Rating: No stars

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:INFI.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Bigsef77 (47.15)
Submitted October 02, 2018

Infinity Pharmaceuticals Earns $22 Million Payment From Verastem Oncology For FDA Approval Of COPIKTRA™ (duvelisib) And Updates 2018 Financial GuidancePR Newswire PR Newswire•October 1, 2018CAMBRIDGE, Mass., Oct. 1, 2018 /PRNewswire/ -- Infinity… More

TrackUltraLong (< 20)
Submitted November 04, 2011

http://www.fool.com/investing/general/2011/07/15/3-stocks-near-52-week-highs-worth-selling.aspx

NASDAQ:INFI.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about INFI.DL.

No one has written a Pitch for INFI.DL stock yet. Tell us why you think INFI.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in INFI.DL.

No players have picked INFI.DL yet. Tell us why you think INFI.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for INFI.DL.